COVID-Era Trial Flexibilities, Equity Focus, Could Be Used To Reshape Cancer Study Enrollment

 
• By Sarah Karlin-Smith
  
older woman stretching
FDA may allow trials to keep pandemic flexibilities to increase study diversity • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Diversity & Inclusion

More from Clinical Trials